Skip to main content
Ryan Rader, MD, Oncology, Lee's Summit, MO

RyanKentRaderMD

Oncology • Lee's Summit, MO

Breast Cancer

Physician

Join to view full profile

Dr. Rader is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Rader's full profile

Already have an account?

  • Office

    4881 NE Goodview Circle
    Lee's Summit, MO 64064
    Phone+1 913-588-1227

Summary

  • Dr. Ryan Rader is a Clinical Assistant Professor of Medical Oncology at the University of Kansas with a primary focus on breast cancer. He completed his Hematology/Oncology fellowship at Duke University and internal medicine residency at Cleveland Clinic. He received his medical degree from University of Missouri-Columbia School of Medicine.

Education & Training

  • Duke University Hospital
    Duke University HospitalFellowship, Hematology and Medical Oncology, 2020 - 2023
  • Cleveland Clinic Foundation
    Cleveland Clinic FoundationResidency, Internal Medicine, 2017 - 2020
  • University of Missouri-Columbia School of Medicine
    University of Missouri-Columbia School of MedicineClass of 2017

Certifications & Licensure

  • KS State Medical License
    KS State Medical License 2023 - 2025
  • MO State Medical License
    MO State Medical License 2023 - 2025
  • NC State Medical License
    NC State Medical License 2020 - 2024
  • OH State Medical License
    OH State Medical License 2020 - 2023
  • AL State Medical License
    AL State Medical License 2021 - 2021
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Press Mentions

  • Patient Selection Takes Priority as Standard of Cares Shift in HR+ and HER2+ Breast Cance
    Patient Selection Takes Priority as Standard of Cares Shift in HR+ and HER2+ Breast CanceJuly 14th, 2024

Professional Memberships

Dr. Ryan Rader, Dr. Ryan Rader, MD, Dr. R Rader, Dr. Ryan Kent Rader